Skip to content

Ambulatory blood pressure control and home blood pressure (morning and evening) lowering by N-channel blocker cilnidipine study

Ambulatory blood pressure control and home blood pressure (morning and evening) lowering by N-channel blocker cilnidipine study - Ambulatory blood pressure control and home blood pressure (morning and evening) lowering by N-channel blocker cilnidipine study (ACHIEVE ONE)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000003695
Enrollment
3000
Registered
2010-06-04
Start date
2008-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Interventions

None listed

Sponsors

Ajinomoto Pharmaceuticals Co., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Atelec-naive patients with essential hypertension

Exclusion criteria

Exclusion criteria: Pregnant or possibly pregnant patients

Design outcomes

Primary

MeasureTime frame
Change in blood pressure levels at home (early morning and before bedtime) or in physician's office

Secondary

MeasureTime frame
Adverse events

Countries

Japan

Contacts

Public ContactEiichi Ohara

Mochida Pharmaceutical Co.,Ltd. Post-Marketing Surveillance

atelec.ms.tokutei@mochida.co.jp03-3225-6342

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026